The lung microbiome and probiotics for respiratory infection


This article explores the role of the lung microbiome, the gut–lung axis, and the current evidence relating to the use of probiotics in the prevention and treatment of respiratory tract related infection. By Dr Brett MacFarlane, PhD, BPharm (Hons), Chief Pharmacist with the Australian College of Pharmacy. Learning objectives After completing this activity, pharmacists should

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?